This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
References
Prosser LA, et al. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations. Annals of Internal Medicine : 19 Feb 2019. Available from: URL: http://dx.doi.org/10.7326/M18-2347
Shafran SD. Prevention of Shingles: Better Protection and Better Value With Recombinant Vaccine. Annals of Internal Medicine : 19 Feb 2019. Available from: URL: http://dx.doi.org/10.7326/M19-0141
Rights and permissions
About this article
Cite this article
Recombinant zoster vaccine cost effective in older adults. PharmacoEcon Outcomes News 823, 27 (2019). https://doi.org/10.1007/s40274-019-5717-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5717-9